Caisse Des Depots Et Consignations Gilead Sciences, Inc. Transaction History
Caisse Des Depots Et Consignations
- $2.39 Trillion
- Q2 2025
A detailed history of Caisse Des Depots Et Consignations transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Caisse Des Depots Et Consignations holds 73,552 shares of GILD stock, worth $8.11 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
73,552
Previous 75,184
2.17%
Holding current value
$8.11 Million
Previous $8.42 Billion
3.2%
% of portfolio
0.34%
Previous 0.41%
Shares
3 transactions
Others Institutions Holding GILD
# of Institutions
2,292Shares Held
1BCall Options Held
9.59MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$13 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.56 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.02 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.91 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...